Valeant Pharma (VRX) volatility spikes after Left said to take new short
Valeant Pharma (NYSE: VRX) July call option implied volatility is at 123, compared to closing level of 82 last night, August is at 94, compared to a closing level of 86, after Citron's Andrew Left said to take a new short stake and says worth $0.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Levi (LEVI) call put ratio 1 call to 1.2 puts into quarter results
- Oracle (ORCL) call put ratio 2.8 calls to 1 put as share price down 3.5%
- Western Digital (WDC) call put ratio 1 call to 2.6 puts as share price down 9.8%
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share